These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37059301)

  • 1. Disulfide bond reduction and exchange in C4 domain of von Willebrand factor undermines platelet binding.
    Kutzki F; Butera D; Lay AJ; Maag D; Chiu J; Woon HG; Kubař T; Elstner M; Aponte-Santamaría C; Hogg PJ; Gräter F
    J Thromb Haemost; 2023 Aug; 21(8):2089-2100. PubMed ID: 37059301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and dynamics of the platelet integrin-binding C4 domain of von Willebrand factor.
    Xu ER; von Bülow S; Chen PC; Lenting PJ; Kolšek K; Aponte-Santamaría C; Simon B; Foot J; Obser T; Schneppenheim R; Gräter F; Denis CV; Wilmanns M; Hennig J
    Blood; 2019 Jan; 133(4):366-376. PubMed ID: 30305279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disulfide bond reduction of von Willebrand factor by ADAMTS-13.
    Yeh HC; Zhou Z; Choi H; Tekeoglu S; May W; Wang C; Turner N; Scheiflinger F; Moake JL; Dong JF
    J Thromb Haemost; 2010 Dec; 8(12):2778-88. PubMed ID: 20946172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gain-of-Function Variant p.Pro2555Arg of von Willebrand Factor Increases Aggregate Size through Altering Stem Dynamics.
    Huck V; Chen PC; Xu ER; Tischer A; Klemm U; Aponte-Santamaría C; Mess C; Obser T; Kutzki F; König G; Denis CV; Gräter F; Wilmanns M; Auton M; Schneider SW; Schneppenheim R; Hennig J; Brehm MA
    Thromb Haemost; 2022 Feb; 122(2):226-239. PubMed ID: 33385180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A biophysical view on von Willebrand factor activation.
    Löf A; Müller JP; Brehm MA
    J Cell Physiol; 2018 Feb; 233(2):799-810. PubMed ID: 28256724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox control of β2-glycoprotein I-von Willebrand factor interaction by thioredoxin-1.
    Passam FH; Rahgozar S; Qi M; Raftery MJ; Wong JW; Tanaka K; Ioannou Y; Zhang JY; Gemmell R; Qi JC; Giannakopoulos B; Hughes WE; Hogg PJ; Krilis SA
    J Thromb Haemost; 2010 Aug; 8(8):1754-62. PubMed ID: 20979592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and function of snake venom toxins interacting with human von Willebrand factor.
    Matsui T; Hamako J
    Toxicon; 2005 Jun; 45(8):1075-87. PubMed ID: 15922776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biophysical approaches promote advances in the understanding of von Willebrand factor processing and function.
    Löf A; Müller JP; Benoit M; Brehm MA
    Adv Biol Regul; 2017 Jan; 63():81-91. PubMed ID: 27717713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking von Willebrand factor free thiols inhibits binding to collagen under high and pathological shear stress.
    O'Brien HER; Zhang XF; Sanz-Hernandez M; Chion A; Shapiro S; Mobayen G; Xu Y; De Simone A; Laffan MA; McKinnon TAJ
    J Thromb Haemost; 2021 Feb; 19(2):358-369. PubMed ID: 33075181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removal of the vicinal disulfide enhances the platelet-capturing function of von Willebrand factor.
    Tischer A; Moon-Tasson L; Auton M
    Blood; 2023 Mar; 141(12):1469-1473. PubMed ID: 36603190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A factor VIII-derived peptide enables von Willebrand factor (VWF)-binding of artificial platelet nanoconstructs without interfering with VWF-adhesion of natural platelets.
    Haji-Valizadeh H; Modery-Pawlowski CL; Sen Gupta A
    Nanoscale; 2014 May; 6(9):4765-73. PubMed ID: 24658160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutual A domain interactions in the force sensing protein von Willebrand factor.
    Posch S; Aponte-Santamaría C; Schwarzl R; Karner A; Radtke M; Gräter F; Obser T; König G; Brehm MA; Gruber HJ; Netz RR; Baldauf C; Schneppenheim R; Tampé R; Hinterdorfer P
    J Struct Biol; 2017 Jan; 197(1):57-64. PubMed ID: 27113902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A molten globule intermediate of the von Willebrand factor A1 domain firmly tethers platelets under shear flow.
    Tischer A; Madde P; Blancas-Mejia LM; Auton M
    Proteins; 2014 May; 82(5):867-78. PubMed ID: 24265179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Local Disorder in a Clinically Elusive von Willebrand Factor Provokes High-Affinity Platelet Clumping.
    Tischer A; Machha VR; Frontroth JP; Brehm MA; Obser T; Schneppenheim R; Mayne L; Walter Englander S; Auton M
    J Mol Biol; 2017 Jul; 429(14):2161-2177. PubMed ID: 28533135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Force sensing by the vascular protein von Willebrand factor is tuned by a strong intermonomer interaction.
    Müller JP; Mielke S; Löf A; Obser T; Beer C; Bruetzel LK; Pippig DA; Vanderlinden W; Lipfert J; Schneppenheim R; Benoit M
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1208-13. PubMed ID: 26787887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of the von Willebrand factor-A1 domain with platelet glycoprotein Ib/IX. The role of glycosylation and disulfide bonding in a monomeric recombinant A1 domain protein.
    Cruz MA; Handin RI; Wise RJ
    J Biol Chem; 1993 Oct; 268(28):21238-45. PubMed ID: 8407961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of the loss of intrachain- versus interchain-disulfide bonds in the cystine-knot domain of von Willebrand factor on the clinical phenotype of von Willebrand disease.
    Tjernberg P; Vos HL; Spaargaren-van Riel CC; Luken BM; Voorberg J; Bertina RM; Eikenboom JC
    Thromb Haemost; 2006 Dec; 96(6):717-24. PubMed ID: 17139364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro phosphorylation of von Willebrand factor by FAM20c enhances its ability to support platelet adhesion.
    Da Q; Han H; Valladolid C; Fernández M; Khatlani T; Pradhan S; Nolasco J; Matsunami RK; Engler DA; Cruz MA; Vijayan KV
    J Thromb Haemost; 2019 Jun; 17(6):866-877. PubMed ID: 30864273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration in GPIIb/IIIa Binding of VWD-Associated von Willebrand Factor Variants with C-Terminal Missense Mutations.
    König G; Obser T; Marggraf O; Schneppenheim S; Budde U; Schneppenheim R; Brehm MA
    Thromb Haemost; 2019 Jul; 119(7):1102-1111. PubMed ID: 31035301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disulfide bonds required to assemble functional von Willebrand factor multimers.
    Dong Z; Thoma RS; Crimmins DL; McCourt DW; Tuley EA; Sadler JE
    J Biol Chem; 1994 Mar; 269(9):6753-8. PubMed ID: 8120035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.